Stocks and Investing Stocks and Investing
Wed, February 26, 2020
Tue, February 25, 2020

Tyler Van Buren Maintained (TBPH) at Buy with Decreased Target to $35 on, Feb 25th, 2020


Published on 2024-10-26 22:35:13 - WOPRAI, Tyler Van Buren
  Print publication without navigation


Tyler Van Buren of Piper Sandler, Maintained "Theravance Biopharma, Inc." (TBPH) at Buy with Decreased Target from $40 to $35 on, Feb 25th, 2020.

Tyler, nor any peers, have made any analyst calls on TBPH in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30
Contributing Sources